chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MDDS, or disembarkment syndrome; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received her first dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in arm right on 06Mar2021 15:00 (at the age of 37 years old) (Lot Number: EN6206) as single dose for COVID-19 immunisation. Medical history included hay fever, depression and allergies to penicillin. The patient was not pregnant at the time of vaccination. The patient did not have COVID prior to vaccination. The patient's concomitant medications were not reported. No other vaccines were administered within four weeks. One week after (reported as 15Mar2021 12:00 AM) patient took the vaccine, she thought she had an ear infection. She went to the ear nose and throat doctor who diagnosed her with MDDS, or disembarkment syndrome, which includes constant dizziness and rocking. She has joined a support group as the symptoms have continued and worsened. She mentioned that there are a couple of other people in the group whose symptoms either started or worsened after their vaccine. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and the seriousness reported was disability or permanent damage. The patient was treated with antibiotics, steroids and physical therapy. The patient did not get tested for COVID post vaccination. The outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 30-APR-2014, the patient was vaccinated with a dose of improperly stored ZOSTAVAX (dose and Lot# not reported). No symptoms were reported. Additional information has been requested.
Swelling of lymphnode on left armpit , resolved by itself after 4 days, along with left sore arm. Narrative:
Arm red and swollen from injection site to elbow. Red patches on arm Headache over 48 hours Flu like symptoms
Generalized rash developed within past 3 days 5/25/09. Blisters - vesicles with fluid - fatigue.
Fever, body aches, chills, headache treated with tylenol and Motrin on day after vaccine, then Headache for half of  2nd day, then normal health.
Immediately has a fire engine red face, neck, chest and arms; tingling in tongue and fingertips; cough. Went to ED and received IV benedryl and steroids.  Given a script for epi pen. Following IV's skin color returned to normal and discharged home without incident.
Pt went to bed immediately p/clinic because didn't feel well; By 730, had temp of 104, was confused & vomiting; Taken to ER where fever was brought down; Continues to give APAP to pt;
Moderna 044A21A taken at 11:40.  By 3:00 am I woke up to a fever of 103.1 aches in muscles, joints, just all over, This lasted until 8:oo am. My wife found some Tylenol which helped, I've been taking 2 every 4 hours. My fever is down but I will go into another night of pain        and weakness.
Patient got up from chair to pick up his phone and collapsed, diaphoretic.  There was no loss of consciousness.  Initial BP = 80/60 and HR =84.   He had no symptoms other than sweating and dizzyness.  He stated he felt dizzy after the vaccine but had not eaten since the night before.   He also said sometimes gets dizzy after shots.  Repeat BP was 110/60 EKG by EMS demonstrated ST wave changes and patient was sent to Medical Center by EMS.
very painful left arm (Thurs - ongoing),  redness (Fri-Sat ongoing), swelling (Thur-),  lack of energy and motivation, (Fri, Sat ongoing), lack of appetite (Fri-Sat ongoing)
Bilateral PE; Distal DVT; Numbness; Tingling; This case was reported by a other health professional via sales rep and described the occurrence of pulmonary embolism in a 62-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd November 2022, the patient received Shingrix. On 8th December 2022, 35 days after receiving Shingrix, the patient experienced pulmonary embolism (serious criteria GSK medically significant), deep vein thrombosis (serious criteria GSK medically significant), numbness and tingling. On an unknown date, the outcome of the pulmonary embolism, deep vein thrombosis, numbness and tingling were unknown.   It was unknown if the reporter considered the pulmonary embolism, deep vein thrombosis, numbness and tingling to be related to Shingrix.     Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comments: The healthcare professional reported that the patient received a dose of Shingrix around first week on November 2022 and diagnosed with bilateral pulmonary embolism, distal vein thrombosis and experienced numbness and tingling. Additional Supportive Information: The vaccination date and event onset date captured as per query clarification received.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64-year-old male patient received BNT162b2 (BNT162B2), on 30Sep2021 as dose 3 (booster),single (Lot number: FF2587) at the age of 64 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Thyroid Disease", start date: 01Jan2005, stop date: 17May2017, notes: Pertinent Details: Radiation Therapy; "Pre Diabetes", start date: 01Jun2018 (ongoing), notes: Stop date: ongoing, Pertinent Details: Metformin pills- diet/Exercise; "Diabetes" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing). Concomitant medication(s) included: TYLENOL, start date: 21Jun2022. Vaccination history included: BNT162b2 (DOSE:2, Anatomical location: Left arm, Batch/lot number: ER8737), administration date: 08Apr2021, when the patient was 63-year-old, for Covid-19 Immunization; BNT162b2 (DOSE;1, Anatomical location: Left arm, Batch/lot number: EN6208), administration date: 11Mar2021, when the patient was 63-year-old, for Covid-19 Immunization. The following information was reported: TINNITUS (non-serious), outcome "not recovered". The event "tinnitus" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Therapeutic measures were taken as a result of tinnitus. Follow up has been requested.
My lungs were not happy when I started 8/16/2021. So I did use the nebulizer that day. That may not necessarily relate to the vaccine because I already had problems. But then I felt better and didn't use my nebulizer for several days. But by the time it was the 8/26, that's when my lungs did not start feeling good again. So I had to use my nebulizer again. On the 8/27, I was having my asthma cough again. And I couldn't talk without struggling to breathe. And I had to use my c-pap again but then I couldn't get that to seal properly because nasal tissue was inflamed. On 8/28 that's when I realized that my neck lymph nodes were really swollen. And I did not have that reaction to the prior 2 vaccinations. By 8/29 I could see that the swelling on my neck lymph nodes were going down. And the 9/1 I noted that I was having trouble speaking sentences without the asthma cough again. And I was using the nebulizer and trying to self manage with the nebulizer. I was using the nebulizer every day and then starting 9/22 that's when the doctor told me to use my maintenance inhaler twice a day for two weeks. So when I did the inhaler I did 2 puffs total of 4 puffs daily for two weeks. The last day of twice a day inhaler was 10/5 and I stopped the daily nebulizer on 10/2/2021. 10/6 return to maintenance inhaler once a day.
pt recv vax;approx 5 hr later, T inc & pt was limp;apap given;that noc, T 105 PO; apap given & was observed for 2-3 hr;T down w/ apap; T gone by next pm;
No adverse event - patient feeling well. FOC reports there was excessive bleeding at injection site but MA states there was none and FOC was not present at time of injection.  Pfizer COVID 19 first dose maroon top UNDILUTED 0.2mL given to patient.
Rash covering my neck, breasts, abdomen and back.   The rash is pink and slightly raised and itchy at times.
injection site reaction of redness had spread now, the redness was all around his biceps, upper arm and deltoids in left arm; injection site reaction of redness that has spread now. reaction is "very red but not itching as much as it was yesterday",; reaction is "very red but not itching as much as it was yesterday"; This spontaneous report was received from a pharmacist, referring to a 65-year-old male patient. Information about concomitant medication, pertinent medical history and drug reactions/ allergies was unknown.  On 22-SEP-2020 (also reported as 2 days ago), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (1 dose, lot # T016160, expiration date 13-FEB-2022; strength and route were unknown) in the left arm deltoid for prophylaxis.  On 23-SEP-2020, the patient experienced injection site reaction of redness and itching. On 24-SEP-2020 (reported as now), injection site reaction of redness had spread, the redness was all around his biceps, upper arm and deltoids in left arm, and the reaction was very red but not itching as much as it was yesterday. The reporter would like to know if she needed to do something for this and how to manage this reaction. There was no treatment given to the events. The patient had sought medical attention. There was no intervention given to prevent serious criteria. The outcome of all events was reported as not recovered. The causality assessments between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and all events was unknown.  This is one of the two cases reported by the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T016160; expirationdate: 13-FEB-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2009USA010590:
Subsequently post vax, The pt developed systemic lupus erythematosus and sought unspecified medical attention. Upon medical review, the pt's systemic lupus was considered an
Immediately upon receiving vaccine, patient complained of "hot flash" and feeling dizzy and had the urge to vomit; appeared pale. Patient was monitored and vitals were normal. After 15min of monitoring, patient complained of swelling in throat - staff provided diphenhydramine liquid 20mL /50mg. Patient was transported to ER, and described numbness an tingling in arm receiving vaccine en route. Patient was discharged following short evaluation in ER.
Diarrhea. Poo oily - oil floated on the water. Hives. Hand pain (bone pain) - nerve.
Has had breakthrough episode of shingles/Suspected vaccination failure; Has had breakthrough episode of shingles; Muscle aches; Redness; Swelling; This serious case was reported by a consumer via sales rep and described the occurrence of vaccination failure in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles in the past).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Has had breakthrough episode of shingles/Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Has had breakthrough episode of shingles), muscle pain (Verbatim: Muscle aches), erythema (Verbatim: Redness) and swelling (Verbatim: Swelling). The outcome of the vaccination failure was unknown and the outcome of the shingles, muscle pain, erythema and swelling were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, muscle pain, erythema and swelling to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, muscle pain, erythema and swelling to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 03-APR-2023 The case was self-reported by the patient. The patient was over 50 years age. The patient received a dose of Shingles shot and it caused muscle aches, redness, swelling.  The patient said she had breakthrough episode of shingles on her lower back and back of her upper leg. The patient reported that it was always only on one side of her body. The patient asked if Shingrix was a 1x only. The follow-up would not be possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
It started with postnasal drip like a drippy throat. I had chest tightness due to asthma and those were the only symptoms I had. My whole family had COVID-19 prior to me getting these symptoms so I had been testing daily. I took a COVID-19 home test on 02/04/2023 and I called my provider who is an allergist. I was prescribed PAXLOVID by my primary care provider. My allergist prescribed PULMICORT 3 times a day and breathing treatments 3 times per day. I was also prescribed XOPENEX. I felt better a day after taking PAXLOVID. I had fatigue on and off and was not feeling well in general. The throat was better along with the postnasal drip. I still felt unwell, and the chest tightness returned after I was done with the course of PAXLOVID was completed. My symptoms became elevated, and I was having issues with exertion, talking and general activity. I was prescribed prednisone 40mg for 6 days. The dosage was reduced by 5 mg daily. I took another 2 weeks. The symptoms were slowly getting better. I was still taking the breathing treatments also. I returned to the doctor for a follow up and was cleared. My stamina is still not where it should be. I still have a little shortness of breath with exertion, but it is getting better.
Narrative:  72yo male patient with the following-PROBLEM LIST: Depression (SCT 35489007) Cervical radiculopathy (SCT 54404000) Diabetes mellitus (SCT 73211009) Essential hypertension (SCT 10725009) Other Unspecified Counseling (ICD-9-CM VCalculus of kidney and ureter (SCT 266556005) Tremor (ICD-9-CM 781.0) Benign hypertension (ICD-9-CM 401.9) Hyperlipidemia (SCT 55822004) Health Maintenance (ICD-9-CM V65.9) Diabetes Mellitus Type II or unspecifiedHypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) Depression (SCT 35489007) Herpes (ICD-9-CM 054.9) died on 11/26/21 after self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 11/26/2021 Chief complaint: Cardiopulmonary arrest Pt had received covid vaccines on 1/29/21 & 3/4/21. This death is not related to vaccinations.
Participant got a rash on back down the right side of body and had a low grade fever approximate 101, was diagnosed with shingles. Shingles cleared on 1/23/2021, about 2-3 weeks later was hospitalized with myocarditis on Feb 7 for a week. Participant has been home rest since leaving hospital. Participant still having dizziness and fatigue.
Child developed a generalized erythematous rash 6 days after the vaccine was administered. The rash is erythematous, itches, some lesions different in sizes. Others show a pale center with an erythematous base that resemble "target lesions." Some of the erythemas are confluent behind the ears measuring approximately 2 X 3 inches. Child was placed on Benadryl Liquid 5mg/kg/day in divided doses 4 times a day. Also there was no mucosal involvement, no swelling of the tongue, no difficulty breathing, no hoarseness, no weak pulse or paleness noted. Child was happy and walking about in no apparent distress of any type.
This case was considered medically important. Information regarding Prevnar was received from a healthcare professional regarding a 6-year-old female patient who experienced low titer levels and really bad pneumonia despite receiving all four doses of Prevnar. The patient received the fourth dose on 19-Jul-2002. In Jul-2007, the patient was taking "omnicef for a strep infection" when her condition worsened. On 27-Jul-2007, the patient spiked a temperature and a chest x-ray was performed. On 28-Jul-2007, lab titers were drawn. Levels were above 0.15 for all serotypes, a few were very close, which the physician considered low. A culture was not taken at this time as the patient was undergoing antibiotic therapy. The doctor stated the chest x-ray was indicative of pneumonia. The physician noted the patient experienced really bad pneumonia despite receiving all four doses of Prevnar. The patient had scheduled a follow-up appointment for Sep-2007. Treatment for the patient was unknown. At the time of the report, it was unknown if the patient had recovered. Follow-up information has been requested.
Condom broke during sex, not sure what day. Took ovral she had on hand. Positive pregnancy test 3/1. Confirmed blood test 3/3/03. Spontaneous and complete abortion 3/11/03 1 p.m. Confirmed by blood test 3/3/03.
Red circle, appx. 1 1/2 inch diameter on upper left shoulder in area of Vaccine administered.  Tingling and pain in mouth and gums
Client received 2nd flu vaccine today. She had already received flu vaccine on 10/28/2022. Client did not have any signs or symptoms of allergic reaction.
Information was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 04-SEP-2015 the patient was supposed to receive a dose of ZOSTAVAX. Instead, the patient inadvertently received a dose of (Merck) VARIVAX (dose, strength and route unknown) (wrong drug administered). This occurred at an unspecified pharmacy. No symptom was reported. Additional information has been requested.
Fever CHILLS, FATIGUE, WEAKNESS, SWELLING AND SORENESS AT INJECTION SITE Narrative:  Other Relevant History:
Difficulty and painful swallowing on left side of throat + severe neck pain on left side.  All symptoms are left side only.
Patient was given Moderna booster dose.  Child is 15 years old.  No adverse reactions noted during  waiting period.
unknown, no notes received. Please call doctor provided and Hospital for notes and information. Patient tested positive for Covid-19 on 10/24/2022
Rash on trunk, front and back. Raised red papular, itches. No treatment at present.
I took the vaccine and two days after I tested positive/had lost my sense of smell and taste; I took the vaccine and two days after I tested positive/had lost my sense of smell and taste; Lost my sense of smell and taste; Lost my sense of smell and taste; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer stated that he/she just got the vaccine on Wednesday (23Dec2020), and he/she started experiencing some symptoms on 24Dec2020 where he/she had lost his/her sense of smell and taste. On 25Dec2020, he/she went 'health' to get tested, and he/she tested positive. The consumer is asking whether this has been reported that one of the side effects of getting the vaccine. The consumer said he/she hasn't read anything about loss of taste and smell after taking the vaccine. He/she was wondering if this has been reported or this is one of those small side effects that the vaccine has. The consumer further stated that he/she took the vaccine and two days after, he/she tested positive. Now, his/her whole family is also positive but only his/herself had the vaccine, because he/she is the only one that works in healthcare (further clarification was unknown, hence reporter was captured as consumer). The outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number could not be obtained. No further information is expected.; Sender's Comments: The association between the event lack of effect (COVID19, lost of taste and smell) with BNT162b2 can not completely excluded.
SHARP CHEST PAIN; TINGLING SENSATION ON THE VACCINATED ARM; NUMBNESS ON THE VACCINATED ARM; This spontaneous report received from a consumer concerned a 57 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included pinch spinal nerves.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUN-2021, the subject experienced sharp chest pain. On JUN-2021, the subject experienced tingling sensation on the vaccinated arm. On JUN-2021, the subject experienced numbness on the vaccinated arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from numbness on the vaccinated arm, and tingling sensation on the vaccinated arm, and the outcome of sharp chest pain was not reported. This report was non-serious.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information has been received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 10-SEP-2013, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 07-DEC-2015, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. On or about 13-JAN-2016, the patient sought subsequent treatment from another physician for continued and worsening symptoms of shingles that has spread to the eyes and neurological interference. The patient was diagnosed with herpes zoster keratitis (shingles in the eyes) and post-herpetic neuralgia. The patient was prescribed valacyclovir HCL (VALTREX) and gabapentin for management of his painful symptoms. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is not recovered. Upon internal review, herpes zoster keratitis (shingles in the eyes) was determined to be medically significant. Additional information has been requested.
Fever, aches, chills, slight cough/phlegm that persisted for over a week, fatigue, headache
My supraclavicular lymph node blew up and was painful to touch the day after vaccine 2 on the right side.  Vaccine was given in right arm.  Warm compresses. Evaluated by NPtoday , one week post second vaccine.  Smaller and less tender but still very visible and palpable.  Watching one additional week prior to having a scan
One day of extreme fatigue Two following days of diarrhea No treatment beyond Kaopectate
idiopatic syncope, patient fainted immediately after injections awoke in about 15 seconds was weak and a little unstable we called 911 at moms request, paramedic concurred with a diagnosis of ipiopathic syncope